申请人:Boehringer Ingelheim International GmbH
公开号:US07928103B2
公开(公告)日:2011-04-19
Compounds of formula (I) are disclosed. Compounds according to the invention are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
公式(I)的化合物已被披露。本发明的化合物是CB2受体的激动剂、拮抗剂或反向激动剂,并且对于治疗炎症是有用的。那些是激动剂的化合物还可用于治疗疼痛。